Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02897128 · ClinicalTrials.gov registry record
Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma
A clinical trial of Sarcoma, Soft Tissue, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 39
- Enrollment target
- 4
- Study locations
NCT02897128 is a study of Sarcoma, Soft Tissue that has completed, run by The Cleveland Clinic. The registered enrollment target is 39 participants, below the 70-participant average among 4 other Sarcoma, Soft Tissue trials with a reported enrollment target (44% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT02897128, a study of Sarcoma, Soft Tissue, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 4
- Study locations
Study Summary
Wound complications after sarcoma resection are frequent and potentially devastating problem. The burden of surgical wound complications in the lower extremity after preoperative external beam radiation therapy (EBRT) for soft tissue sarcoma is estimated at 43%. A noninvasive method of predicting complications would be extremely beneficial. The aim of this study is to evaluate the relationship between preoperative skin oxygenation and wound outcomes in a multi-center prospective analysis. This information could lead to a change in practice regarding surgical timing and adjunctive interventions to improve wound healing outcomes.
Conditions Studied
Interventions
- OTHER Observational Only - Transcutaneous Oxygen Measurement
Study Locations (4)
Florida
- University of Florida - Gainesville
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Ohio
- Cleveland Clinic - Cleveland
Oklahoma
- University of Oklahoma - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2016-07 |
| Est. Completion | 2021-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02897128
The ClinicalTrials.gov registry entry for NCT02897128 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 70-participant average among 4 other Sarcoma, Soft Tissue trials with a reported enrollment target (44% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sarcoma, Soft Tissue appearing as the primary indexed condition, and to 1 intervention - of which Observational Only - Transcutaneous Oxygen Measurement is the first listed.
NCT02897128 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Iowa, Ohio.
Frequently Asked Questions
What is clinical trial NCT02897128 about?
NCT02897128 is a clinical study titled "Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma". Wound complications after sarcoma resection are frequent and potentially devastating problem. The burden of surgical wound complications in the lower extremity after preoperative external beam radiation therapy (EBRT) for soft tissue sarcoma is estimated at 43%. A noninvasive method of predicting co...
What is the current status of trial NCT02897128?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2016-07. Estimated completion is 2021-01-15.
What conditions does trial NCT02897128 study?
This clinical trial studies the following conditions: Sarcoma, Soft Tissue.
What interventions are being tested in trial NCT02897128?
The interventions under investigation include: Observational Only - Transcutaneous Oxygen Measurement (OTHER).
Who is sponsoring clinical trial NCT02897128?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02897128 being conducted?
This trial has 4 study locations across Florida, Iowa, Ohio, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma, Soft Tissue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
RECRUITING · Phase 2
-
Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma
ACTIVE NOT RECRUITING · Early Phase 1
-
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
COMPLETED · Phase 3
-
A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.